Schedule an Evaluation A consultation does not guarantee that IV treatment will be recommended What to Expect During an NAD+ or Glutathione IV Session History, medicines, allergies, vital signs, hydration status, pregnancy considerations, previous infusion reactions, and the intended product should be reviewed
Our experience guiding research teams through peptide protocols shows the same pattern: underdosing is far more common than overdosing, and most 'non-responders' correct their response by recalculating dose based on vial concentration and body weight (0.01mg per kg is a functional starting point for loading)
Side effects from doing so are rare
The approval was based on the OASIS clinical trial programme and the SELECT cardiovascular outcomes trial, with the OASIS 4 study showing a mean weight loss of 16.6% at 64 weeks in adults with obesity or overweight, among participants who adhered to treatment
The positive results were not identified in any of the control groups